1. by Karl-Georg Fischer, Barbara Deschler, and Michael Lübbert
Acquired high-titer factor VIII inhibitor: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses
by Karl-Georg Fischer, Barbara Deschler, and Michael Lübbert
Blood
Volume 101(9):
May 1, 2003
©2003 by American Society of Hematology

2. Multimodal treatment of acquired factor VIII inhibitor
Multimodal treatment of acquired factor VIII inhibitor.Time course of activated partial thromboplastin time (aPTT, ●), factor VIII (○), and factor VIII inhibitor (▴).
Multimodal treatment of acquired factor VIII inhibitor.Time course of activated partial thromboplastin time (aPTT, ●), factor VIII (○), and factor VIII inhibitor (▴). A rapid decline in factor VIII inhibitor is accomplished by plasmapheresis. FEIBA indicates factor VIII inhibitor bypassing activity.
Karl-Georg Fischer et al. Blood 2003;101:
©2003 by American Society of Hematology